Displaying 1-10 of 70 results for

COVID-19 has elevated our nation’s stress level. When not managed properly (or without any buffers like social support) stress is associated with increased depression and anxiety. Because COVID-19 ...

In 2020, the COVID-19 pandemic exacerbated barriers to care and treatment for individuals experiencing opioid use disorder. Experts estimate a record-setting 90,000 people died of a drug overdose in ...

Whatever stage agencies are in addressing the intersection of suicide, overdose, and ACEs, ASTHO’s SPACECAT Capacity Elements Toolkit simplifies action ideas for health agency staff and leadership to ...

As the overdose epidemic continues, it is imperative for the medicolegal death investigative community to understand the importance of continuous training and the role that accurate death ...

Change can take time, but every success improves our capabilities to care for our communities. Explore four powerful, successful programs below.

ASTHO conducted focus groups to examine overdose-related issues and identify potential engagement opportunities for public health and public safety around overdose prevention. This brief outlines key ...

The opioid crisis continues to claim the lives of thousands across the United States and has cost the economy billions in health care, mortality, and criminal justice costs. In 2018, it’s estimated ...

With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To ...

This brief describes how the New Mexico Department of Health has enhanced its harm reduction program to provide an evidence-based comprehensive care model to support the health of people who use ...

This brief highlights how the Georgia Department of Public Health and the Ohio Department of Health developed robust opioid overdose surveillance systems.